- Issuer ticker
-
HCA
- Reported as of
-
29 Oct 2026
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
5 source fields
- SEC form
-
4
- Accepted by SEC
-
02 Nov 2026, 17:52:45 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Kevin A. Ball, Attorney-in-Fact
Filing notes and source
Key filing fact
Michael J. Schlosser filed Form 4 for HCA Healthcare, Inc. (HCA) on 02 Nov 2026.
Key facts
- This page summarizes Michael J. Schlosser's Form 4 filing for HCA Healthcare, Inc. (HCA).
- 6 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 02 Nov 2026, 17:52.
Change
- Previous filing in this sequence was filed on 11 Sep 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0002149484
Primary reporting owner
Schlosser Michael J
- Relationship
-
EVP and Chief Clinical Officer
- Address
- ONE PARK PLAZA, NASHVILLE
- Signature
- /s/ Kevin A. Ball, Attorney-in-Fact
- Signature date
- 02 Nov 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HCA
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +3,030
- Change %
- +1781%
- Price
-
$81.96*
- Shares after
- 3,200
- Date
- 29 Oct 2026
- Ownership
- Direct
HCA
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +1,898
- Change %
- +59%
- Price
-
$82.85*
- Shares after
- 5,098
- Date
- 29 Oct 2026
- Ownership
- Direct
HCA
transaction
Common Stock
Tax liability
- Transaction value
- Shares
- -2,455
- Change %
- -48%
- Price
-
$478.08*
- Shares after
- 2,643
- Date
- 29 Oct 2026
- Ownership
- Direct
HCA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
-
- Shares after
- 6,951
- Date
- 29 Oct 2026
- Ownership
- By 2022 Trust
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
HCA
transaction
Derivative
Stock Appreciation Right
Options Exercise
- Transaction value
- Shares
- -3,030
- Change %
- -100%
- Price
-
$0.000000*
- Shares after
- 0
- Date
- 29 Oct 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,030
- Exercise price
- $81.96
- Footnotes
- F1
HCA
transaction
Derivative
Stock Appreciation Right
Options Exercise
- Transaction value
- Shares
- -1,898
- Change %
- -100%
- Price
-
$0.000000*
- Shares after
- 0
- Date
- 29 Oct 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,898
- Exercise price
- $82.85
- Footnotes
- F2
HCA
transaction
Derivative
Stock Appreciation Right
Award
- Transaction value
- Shares
- +2,797
- Change %
- Price
-
$0.000000*
- Shares after
- 2,797
- Date
- 29 Oct 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,797
- Exercise price
- $478.08
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Explanation of responses
3 footnotes